Ex-CEO of Biofourmis charged over multimillion-dollar invoice fraud involving MOH
Biofourmis' former CEO has been charged with falsifying accounts and forging documents, including US$16.5 million worth of invoices purportedly for services to the Ministry of Health.
- Biofourmis ex-CEO Rajput Kuldeep Singh faces seven criminal charges in Singapore.
- He allegedly directed falsified invoices to claim US$16.5 million in services to MOH.
- A forged letter was allegedly used to deceive DBS Bank for fund transfers.
The former chief executive officer of health technology company Biofourmis Holdings, Rajput Kuldeep Singh Vithal Singh, has been charged in Singapore with multiple offences, including falsification of accounts, fraud, and forgery.
According to The Straits Times, citing charge sheets filed in court, Rajput, 34, appeared before a district court on 4 February 2026 to face seven charges. These include three counts of abetting the falsification of accounts, three charges of fraud by false representation or abetment thereof, and one charge of forgery for the purpose of cheating.
The offences allegedly took place while Rajput was serving as both director and CEO of Biofourmis Holdings Pte Ltd.
Between 18 August 2021 and 28 February 2022, Rajput is said to have instructed his staff to falsify invoices claiming that Biofourmis Singapore had delivered services valued at US$16,491,375 (approximately S$20,941,600) to the Ministry of Health (MOH).
Charge sheets reveal that the invoices pertained to services linked to the Biovitals Sentinel Platform. The platform provides clinicians with real-time patient vital signs through remote monitoring.
Later, from 28 March to 25 April 2022, Rajput allegedly made, and also instigated others to make, fraudulent representations involving Biofourmis Holdings and its subsidiaries.
These representations reportedly included inflated revenue figures and falsified financial statements. One key misrepresentation involved claims that “discussions with the MOH on payment are ongoing”, which, according to the charge sheets, were untrue.
On 29 November 2022, Rajput is further alleged to have forged an employee stock option plan offer letter. This was purportedly intended to deceive DBS Bank into transferring funds, a move the authorities consider an attempt to cheat the bank.
The Singapore Police Force announced in a press release issued on 3 February 2026 that Rajput would be charged for these offences. They outlined the relevant sections of the Penal Code under which the charges are made.
If convicted of fraud by false representation or abetment, Rajput faces up to 20 years’ imprisonment, a fine, or both per charge.
The charges of falsifying accounts, or abetting such falsification, carry a maximum sentence of 10 years’ imprisonment, a fine, or both per count.
Forgery for the purpose of cheating is also punishable with up to 10 years in prison and a fine.
Rajput is currently represented by Faraaz Amzar from Eugene Thuraisingam LLP. During the court session on 4 February, he indicated that he does not intend to plead guilty.
He has been released on bail of S$600,000, and a pre-trial conference is scheduled for 1 April 2026.
Biofourmis is a global technology company now headquartered in Boston, with key offices in Singapore and India.
Originally founded in Singapore, the company shifted its headquarters to the United States following a US$35 million Series B funding round in 2019.
It specialises in digital therapeutics and remote patient monitoring. The Biovitals platform, central to the charges, has been part of healthcare collaborations in multiple countries.
Rajput reportedly moved to Singapore to start a PhD, but he dropped out to start the business with co-founder Wendou Niu in 2015 because he saw the potential to “predict disease before it happens,” he told TechCrunch in an interview.
